While inconsistent dosing could have played a role, it still may be possible to identify the patients most likely to see ...

Ferric carboxymaltose, an IV iron replacement therapy, did not reduce the time to first HF hospitalization or CV death for patients with HF and iron deficiency, according to results of a late-breaking ...

The identification and management of comorbidities are central to the care of patients with atrial fibrillation (AF). The ...

After some high-profile crashes, the one-time biotech darling is inching toward success with its Hunter syndrome treatment, ...

Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron ...

The Patuxent Partnership announced that five students made the Top 5 at the Maryland Regional Junior Science and Humanities ...

Transferrin is the major iron-carrying protein in plasma. It has two receptors, transferrin receptor 1 and transferrin receptor 2. Structurally it has two lobes, N and C, each of which can bind a ...

Ocugen (OCGN) announced that the Data and Safety Monitoring Board for the OCU200 clinical trial recently convened and reviewed safety data ...

转铁蛋白（Transferrin, Tf）修饰负载洛哌丁胺（Loperamide, Lop）的人血白蛋白（HSA）纳米粒是一种创新的药物递送系统，旨在增强洛哌丁胺穿越血脑屏障（BBB）的能力并提高其在中枢神经系统中的镇痛效果。洛哌丁胺通常不能有效穿透血脑屏障，而通过将其包裹在HSA ...

Transferrin (Tf), the major iron-binding protein in plasma, appears to have both cargo and signaling functions. It has two homologous lobes, N and C, each of which can bind one iron molecule. Clefts ...

Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109, United States Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan 48109, United States Biointerfaces ...